We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 216

Faking it: can QR codes combat counterfeit medicines?
  • Gowling WLG
  • Russia
  • January 31 2018

A new federal law aims to eliminate the illegal trafficking of medicines in Russia - including counterfeit, falsified and inferior medicines - by


Invention pertaining to medicine not carte blanche for PMPRB jurisdiction
  • Gowling WLG
  • Canada
  • December 14 2017

On November 9, 2017, the Federal Court released a decision in which it overturned the decision of a Panel of the Patented Medicine Prices Review


Canada’s patented medicines regime: Trending upward and onward
  • Gowling WLG
  • Canada
  • August 1 2017

On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 20162017 for the Patented Medicines (Notice of


Curtain lifted on proposed amended PM(NOC) Regulations
  • Gowling WLG
  • Canada
  • July 17 2017

The curtain has been lifted to reveal the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (the “Amended


The universe of pharmaceutical trademarks in Russia 2017
  • Gowling WLG
  • Russia
  • June 5 2017

Russia is geographically the largest country in the world and has A population of over 140,000,000 people. Consequently the Russian Federation poses


The fight against counterfeit pharmaceutical products intensifies
  • Gowling WLG
  • Global
  • May 15 2017

According to the World Health Organization (WHO) definition, a counterfeit medicine is "a medicine, which is deliberately and fraudulently mislabelled


Incentivising the private healthcare sector in Africa
  • Gowling WLG
  • Africa
  • May 10 2017

Africa is experiencing a period of strong economic growth, which in turn is accelerating the development and diversification of the health and care


TPP: new rights for pharmaceutical patent holders
  • Gowling WLG
  • Canada
  • December 9 2015

On November 5 2015 the Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP). This follows the technical


The TPP new rights for pharmaceutical patent holders in Canada
  • Gowling WLG
  • Canada
  • November 13 2015

The Canadian Government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the


The Trans-Pacific partnership: changes for patents and pharmaceuticals?
  • Gowling WLG
  • Asia-Pacific, Canada
  • October 8 2015

Changes may be on the horizon for Canada’s legal and regulatory regime for patents and pharmaceuticals. Included in the Trans-Pacific Partnership